[en] OBJECTIVE: To determine the association between three fibulin-3 peptides and the incidence of radiographic and clinical knee osteoarthritis (OA). DESIGN: Women between 50 and 60 years, with a BMI >/=27 kg/m2, free of knee OA, were recruited. Using binary logistic regression, the association between baseline concentration of serum fibulin (Fib)3-1, Fib3-2 and Fib3-3 and incidence of clinical and radiographic knee OA after 30 months of follow-up was evaluated. RESULTS: Baseline and follow-up measurements were available for 241 women with a mean age of 55.9 +/- 3.2 years and mean BMI of 31.7 +/- 3.6 kg/m2. None of the concentrations of the three Fib3 epitopes were associated with the incidence of medial or lateral joint space narrowing (JSN) >/=1.0 mm or the incidence of Kellgren & Lawrence (K&L) grade >/=2 after 30 months. All three Fib3 epitopes were associated with the incidence of the clinical and radiographic ACR-criteria and Fib3-1 and Fib3-3 also with chronic pain at follow-up. When adjusted for the other Fib3 peptide concentrations, only Fib3-1 was significantly associated to the incidence of the American College of Rheumatology (ACR)-criteria (OR 3.2 [1.2-8.7]) and chronic pain at follow-up (OR 3.0 [1.2-7.7]). CONCLUSIONS: Baseline fibulin-3 concentrations are associated with the incidence of clinical knee OA among middle-aged overweight and obese women. Therewith, they meet the criteria of a prognostic biomarker according to the BIPED biomarker classification for OA. Further validation of the fibulin-3 epitopes seems warranted in order to better distinguish subgroups of individuals at increased risk for knee OA development.
Research center :
d‐BRU - Dental Biomaterials Research Unit - ULiège [BE]
Loeser R.F., Goldring S.R., Scanzello C.R., Goldring M.B. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 2012, 64:1697-1707. 10.1002/art.34453.
van Spil W.E., DeGroot J., Lems W.F., Oostveen J.C., Lafeber F.P. Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria. Osteoarthritis Cartilage 2010, 18:605-612. 10.1016/j.joca.2010.01.012.
Henrotin Y., Addison S., Kraus V., Deberg M. Type II collagen markers in osteoarthritis: what do they indicate?. Curr Opin Rheumatol 2007, 19:444-450. 10.1097/BOR.0b013e32829fb3b5.
Golightly Y.M., Allen K.D., Helmick C.G., Schwartz T.A., Renner J.B., Jordan J.M. Hazard of incident and progressive knee and hip radiographic osteoarthritis and chronic joint symptoms in individuals with and without limb length inequality. J Rheumatol 2010, 37:2133-2140. 10.3899/jrheum.091410.
Kraus V.B., Burnett B., Coindreau J., Cottrell S., Eyre D., Gendreau M., et al. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage 2011, 19:515-542. 10.1016/j.joca.2010.08.019.
Ehlermann J., Weber S., Pfisterer P., Schorle H. Cloning, expression and characterization of the murine Efemp1, a gene mutated in Doyne-Honeycomb retinal dystrophy. Gene Expr Patterns 2003, 3:441-447. 10.1016/S1567-133X(03)00084-X.
Albig A.R., Neil J.R., Schiemann W.P. Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res 2006, 66:2621-2629. 10.1158/0008-5472.CAN-04-4096.
Klenotic P.A., Munier F.L., Marmorstein L.Y., Anand-Apte B. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1). Implications for macular degenerations. J Biol Chem 2004, 279:30469-30473. 10.1074/jbc.M403026200.
Djokic J., Fagotto-Kaufmann C., Bartels R., Nelea V., Reinhardt D.P. Fibulin-3, -4, and -5 are highly susceptible to proteolysis, interact with cells and heparin, and form multimers. J Biol Chem 2013, 288:22821-22835. 10.1074/jbc.M112.439158.
Henrotin Y., Gharbi M., Mazzucchelli G., Dubuc J.E., De Pauw E., Deberg M. Fibulin 3 peptides Fib3-1 and Fib3-2 are potential biomarkers of osteoarthritis. Arthritis Rheum 2012, 64:2260-2267. 10.1002/art.34392.
de Vos B.C., Runhaar J., Bierma-Zeinstra S.M. Effectiveness of a tailor-made weight loss intervention in primary care. Eur J Nutr 2014, 53:95-104. 10.1007/s00394-013-0505-y.
Runhaar J., van Middelkoop M., Reijman M., Willemsen S., Oei E.H., Vroegindeweij D., et al. Prevention of knee osteoarthritis in overweight females; the first preventive randomized controlled trial in osteoarthritis. Am J Med 2015, 128:888-895. 10.1016/j.amjmed.2015.03.006.
Buckland-Wright J.C., Wolfe F., Ward R.J., Flowers N., Hayne C. Substantial superiority of semiflexed (MTP) views in knee osteoarthritis: a comparative radiographic study, without fluoroscopy, of standing extended, semiflexed (MTP), and schuss views. J Rheumatol 1999, 26:2664-2674.
Kellgren J.H., Lawrence J.S. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957, 16:494-502.
Lequesne M. Quantitative measurements of joint space during progression of osteoarthritis: chondrometry. Osteoarthritic Disorders 1995, 427-444. Rosemont: American Academy of Orthopaedic Surgeons. K. Kuettner, V. Goldberg (Eds.).
Kraus V.B., Vail T.P., Worrell T., McDaniel G. A comparative assessment of alignment angle of the knee by radiographic and physical examination methods. Arthritis Rheum 2005, 52:1730-1735. 10.1002/art.21100.
Lean M.E., Han T.S., Deurenberg P. Predicting body composition by densitometry from simple anthropometric measurements. Am J Clin Nutr 1996, 63:4-14.
Wendel-Vos G.C., Schuit A.J., Saris W.H., Kromhout D. Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol 2003, 56:1163-1169. 10.1016/S0895-4356(03)00220-8.
Roos E.M., Toksvig-Larsen S. Knee injury and Osteoarthritis Outcome Score (KOOS) - validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes 2003, 1:17. 10.1186/1477-7525-1-17.
Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., et al. Development of criteria for the classification and reporting of osteoarthritis. Arthritis Rheum 1986, 29:1039-1049.
Halper J., Kjaer M. Basic components of connective tissues and extracellular matrix: elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, tenascins and thrombospondins. Adv Exp Med Biol 2014, 802:31-47. 10.1007/978-94-007-7893-1_3.
Sharma L., Lou C., Felson D.T., Dunlop D.D., Kirwan-Mellis G., Hayes K.W., et al. Laxity in healthy and osteoarthritic knees. Arthritis Rheum 1999, 42:861-870. 10.1002/1529-0131(199905)42:5.
Sharma L., Eckstein F., Song J., Guermazi A., Prasad P., Kapoor D., et al. Relationship of meniscal damage, meniscal extrusion, malalignment, and joint laxity to subsequent cartilage loss in osteoarthritic knees. Arthritis Rheum 2008, 58:1716-1726. 10.1002/art.23462.
Miura H., Takasugi S., Kawano T., Manabe T., Iwamoto Y. Varus-valgus laxity correlates with pain in osteoarthritis of the knee. Knee 2009, 16:30-32. 10.1016/j.knee.2008.09.003.
Aunan E., Kibsgard T.J., Diep L.M., Rohrl S.M. Intraoperative ligament laxity influences functional outcome 1 year after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2014, 10.1007/s00167-014-3108-0.
Bauer D.C., Hunter D.J., Abramson S.B., Attur M., Corr M., Felson D., et al. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage 2006, 14:723-727. 10.1016/j.joca.2006.04.001.
